197 related articles for article (PubMed ID: 154771)
1. [Disorders of phenylalanine and tyrosine metabolism in Down's syndrome].
Shaposhnikov AM; Khal'chitskiĭ SE; Shvarts EI
Vopr Med Khim; 1979; 25(1):15-9. PubMed ID: 154771
[TBL] [Abstract][Full Text] [Related]
2. [Disorders in the phenylalanine hydroxylase system of the liver in alcoholism].
Shaposhnikov AM; Skachkov MM
Vopr Med Khim; 1977; 23(4):495-9. PubMed ID: 919373
[TBL] [Abstract][Full Text] [Related]
3. Biochemical study of malnutrition. Part V. Metabolism of phenylalanine and tyrosine.
Antener I; Verwilghen AM; van Geert C; Mauron J
Int J Vitam Nutr Res; 1981; 51(3):297-306. PubMed ID: 6119298
[TBL] [Abstract][Full Text] [Related]
4. [Phenylalanine-4-hydroxylase activity in the liver in viral hepatitis].
Shaposhnikova AM; Skachkov MM; Babitskiĭ GIa
Vopr Med Khim; 1977; 23(5):597-601. PubMed ID: 595492
[TBL] [Abstract][Full Text] [Related]
5. [Some indices of phenylalanine and tyrosine metabolism in children with phenylketonuria].
D'iachkova AIa; Lebedev BV
Vopr Okhr Materin Det; 1969; 14(7):29-32. PubMed ID: 5367726
[No Abstract] [Full Text] [Related]
6. Decreased phenylalanine uptake and turnover in patients with vitiligo.
Schallreuter KU; Chavan B; Rokos H; Hibberts N; Panske A; Wood JM
Mol Genet Metab; 2005 Dec; 86 Suppl 1():S27-33. PubMed ID: 16143555
[TBL] [Abstract][Full Text] [Related]
7. Phenylalanine and tyrosine kinetics in compensated liver cirrhosis: effects of meal ingestion.
Tessari P; Kiwanuka E; Vettore M; Barazzoni R; Zanetti M; Cecchet D; Orlando R
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G598-604. PubMed ID: 18653725
[TBL] [Abstract][Full Text] [Related]
8. [Concentration and composition of cerebral gangliosides in Down's disease].
Karpova OB; Obukhova EL; Avrova NF; Shvartz EI
Vopr Med Khim; 1978; 24(4):524-7. PubMed ID: 150702
[TBL] [Abstract][Full Text] [Related]
9. In vivo metabolism of deutero-L-phenylalanine and deutero-L-tyrosine in normal and in various tumor-bearing rats.
Ziegler I; Kokolis N; Stichler W
Cancer Biochem Biophys; 1977; 2(2):71-7. PubMed ID: 616324
[TBL] [Abstract][Full Text] [Related]
10. Significant phenylalanine hydroxylation in vivo in patients with classical phenylketonuria.
Thompson GN; Halliday D
J Clin Invest; 1990 Jul; 86(1):317-22. PubMed ID: 2365821
[TBL] [Abstract][Full Text] [Related]
11. Free amino acid pool in the brain of mice homozygous for the gene "dilute lethal".
Simler S; Essayag S; Ledig M; Koehl C; Mandel P
J Neurosci Res; 1977; 3(4):281-7. PubMed ID: 566796
[TBL] [Abstract][Full Text] [Related]
12. Phenylketonuria. The in vivo hydroxylation rate of phenylalanine into tyrosine is decreased.
van Spronsen FJ; Reijngoud DJ; Smit GP; Nagel GT; Stellaard F; Berger R; Heymans HS
J Clin Invest; 1998 Jun; 101(12):2875-80. PubMed ID: 9637722
[TBL] [Abstract][Full Text] [Related]
13. In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics.
Curtius HC; Zagalak MJ; Baerlocher K; Schaub J; Leimbacher W; Redweik U
Helv Paediatr Acta; 1978 Feb; 32(6):461-9. PubMed ID: 632110
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen metabolites and prooxidant status in children with Down's syndrome.
Carratelli M; Porcaro L; Ruscica M; De Simone E; Bertelli AA; Corsi MM
Int J Clin Pharmacol Res; 2001; 21(2):79-84. PubMed ID: 11824651
[TBL] [Abstract][Full Text] [Related]
15. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
Ratzmann GW; Grimm U; Jährig K; Knapp A
Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
[TBL] [Abstract][Full Text] [Related]
16. On the levels of phenylalanine, tyrosine and tetrahydrobiopterin in the blood of tumor-bearing organisms.
Kokolis N; Ziegler I
Cancer Biochem Biophys; 1977; 2(2):79-85. PubMed ID: 616325
[TBL] [Abstract][Full Text] [Related]
17. [Free plasma and cerebral amino acids in children with Down's syndrome].
Abasheva GK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1068-70. PubMed ID: 6457478
[TBL] [Abstract][Full Text] [Related]
18. Renal impairment in urate excretion in patients with Down's syndrome.
Nishida Y; Akaoka I; Kobayashi M; Maruki K; Oshima Y
J Rheumatol; 1979; 6(1):103-7. PubMed ID: 155745
[TBL] [Abstract][Full Text] [Related]
19. Phenylalanine metabolism in uremic and normal man.
Jones MR; Kopple JD; Swendseid ME
Kidney Int; 1978 Aug; 14(2):169-79. PubMed ID: 357810
[TBL] [Abstract][Full Text] [Related]
20. Effect of liver cirrhosis on phenylalanine and tyrosine metabolism.
Tessari P; Vettore M; Millioni R; Puricelli L; Orlando R
Curr Opin Clin Nutr Metab Care; 2010 Jan; 13(1):81-6. PubMed ID: 19898234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
